Washington, D.C.-based business conglomerate Danaher Corp. is set to acquire privately held Integrated DNA Technologies Inc. for undisclosed terms.
Coralville, Iowa-based IDT manufactures custom DNA and RNA for use in academic and biopharmaceutical research. "IDT expands our presence into the highly attractive genomics market and will help play a central role in accelerating our customers' research and time to market as they develop critical diagnostic tests and potential life-saving therapies," Rainer Blair, executive vice president of Danaher's life sciences platform, said in a statement.
IDT has 1,200 employees and will operate as a stand-alone entity within Danaher's life sciences platform.
The deal, expected to close mid-year 2018, is subject to customary closing conditions and regulatory approvals.
